Drugs / VEE Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03051386 | May 2018 → Apr 2022 | Venezuelan equine encephalitis | U.S. Army Medical Research and Development Command | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VEE Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03051386 ↗ |
| Modality | Vaccine | “VEE vaccine, Live, Attenuated” NCT03051386 ↗ |
| Route | Subcutaneous | “administered subcutaneously” NCT03051386 ↗ |